National Research (NRC) Status update summary
Event summary combining transcript, slides, and related documents.
Status update summary
2 Feb, 2026Key challenges in patient experience measurement
Conflicting data from HCAHPS and patient feedback platforms can create uncertainty and hinder confidence in improvement strategies.
NPS and HCAHPS are strongly related, with similar trends over time, but short-term views can obscure true performance.
Focusing solely on HCAHPS due to its public and financial impact can lead to missed insights and revenue opportunities.
Importance of timely and representative feedback
Timely feedback enables rapid improvement, positive recognition, and effective service recovery, which are critical for staff morale and patient loyalty.
HCAHPS responses are predominantly from patients aged 65+, which may not represent the broader patient population.
Expanding feedback methods, such as web-based surveys, can capture more diverse patient perspectives.
Strategies for improvement and action
Focusing on key drivers like care coordination and nurse communication yields the greatest impact on overall ratings.
Leadership rounding and a supportive culture foster accountability and effective service recovery.
Using real-time feedback in areas like the emergency department can influence inpatient HCAHPS scores, especially for smaller hospitals.
Latest events from National Research
- Q4 2025 revenue rose 2%, TRCV up 8% YoY, and a $0.16 dividend was declared.NRC
Q4 20253 Feb 2026 - Huey AI enhances healthcare experience management with tailored, ethical, and privacy-focused solutions.NRC
Status Update3 Feb 2026 - Significant CAHPS and HCAHPS survey changes and reporting updates are set for 2025–2030.NRC
Status Update22 Jan 2026 - AI and digital tools can transform healthcare if implemented transparently and with human well-being at the core.NRC
Status Update13 Jan 2026 - 2025 proxy seeks approval for director elections, auditor, say-on-pay, and new incentive plan.NRC
Proxy Filing2 Dec 2025 - TRCV grew 2% as Q2 2025 revenue fell and executive compensation drove a net loss.NRC
Q2 202516 Nov 2025 - Q3 2025 saw higher adjusted EBITDA, record retention, and a 33% dividend increase.NRC
Q3 20257 Nov 2025 - Revenue and net income declined, but cash flow and shareholder returns increased.NRC
Q3 202413 Jun 2025 - Revenue and net income fell, but acquisitions and product innovation signal future growth.NRC
Q2 202413 Jun 2025